Back to Stakeholders

Janssen Korea Ltd. is the South Korean affiliate of Janssen Pharmaceuticals, the pharmaceutical subsidiary of Johnson & Johnson. The company markets esketamine nasal spray (Spravato) in South Korea following regulatory approval for treatment-resistant depression and major depressive disorder with acute suicidal ideation.

Academic Research

0 papers

Published Papers

0

Trial Involvement

1

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Subsidiary
HQ
South Korea
Website
Visit

Sponsored Trials

1